FENOFIBRIC ACID

Post-LOE

fenofibric acid

Molecular Devices

ANDAORALCAPSULE, DELAYED RELEASE

Approved

Jun 2020

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

5/8 — Partial

FENOFIBRIC ACID (fenofibric acid) by Molecular Devices is delayed-release capsules is fenofibric acid. Approved for type 2 diabetes mellitus. First approved in 2020.

Drug data last refreshed 20h ago

$0.0BPart D

Mechanism of Action

delayed-release capsules is fenofibric acid. The pharmacological effects of fenofibric acid in both animals and humans have been studied through oral administration of fenofibrate. The lipid-modifying effects of fenofibric acid seen in clinical practice have been explained in vivo in transgenic…

Pharmacologic Class:

Peroxisome Proliferator Receptor alpha Agonist

Indications (1)

type 2 diabetes mellitus

Clinical Trials (3)

NCT00839293Phase 1Completed

Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules

Started Feb 2009

32 enrolled

Healthy

NCT00808678Phase 1Completed

Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium

Started Dec 2008

90 enrolled

Healthy

NCT00826358Phase 1Completed

Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg

Started Nov 2008

90 enrolled

Healthy

Worked on FENOFIBRIC ACID at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.